Close search filters
Changing filters will change the listed Success Criteria and Techniques
Category
Topic
Search results (166)
Newsroom
Express Scripts Sues to Preserve Access to Care for Arkansans
May 29, 2025
Misguided new law will disrupt care for hundreds of thousands of patients, affect fertility treatments, and put Arkansans living with chronic diseases at risk of losing access to their medications.
Newsroom
Express Scripts Further Advances Transparency and Affordability for Consumers and Clients
April 13, 2023
Express Scripts, the pharmacy benefits management business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today announced several actions to further evolve its pharmacy benefit management (...
Article
The importance of a clinical-first approach to formulary development
The clinical efficacy of a drug must always take priority over any other considerations when developing formularies.
Read MoreArticle
Leveraging data, insights, and clinical expertise to support gene and cell therapy treatment
August 28, 2025
Learn more about Evernorth Therapy Link, a new solution designed to identify and support patients who can benefit most from gene or cell therapies.
Newsroom
Evernorth’s Accredo Earns URAC Rare Disease Pharmacy Center of Excellence Designation
February 10, 2022
Newsroom
Evernorth and Kaiser Permanente Enter Strategic Collaboration to Deliver More Convenient, Affordable and Accessible Health Care
April 19, 2022
Broad agreement aims to increase convenience and expand affordable access to valuable health benefits and high-quality care to millions more Americans
Kaiser Permanente members will benefit from ac...
Article
What impact will the Inflation Reduction Act have on health plans?
January 12, 2024
Plan sponsors should be aware of the effects the law will have on Medicare Part D over the coming years.
Article
Express Scripts To Begin Adding Inflammatory Conditions Biosimilars to Largest Formularies Next Year
December 05, 2022